Cargando…
Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
The advent of checkpoint inhibitor immunotherapy has rapidly changed the landscape of the management of cancers. However, its use has also been associated with the rise of immunotherapy-related adverse effects (irAEs). There has been an emergence in recent years of sclerosing cholangitis as a mimic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066501/ https://www.ncbi.nlm.nih.gov/pubmed/37013108 http://dx.doi.org/10.1159/000530009 |